PERSONALISED AZITHROMYCIN+METRONIDAZOLE (PAZAZ), IN COMBINATION WITH STANDARD INDUCTION THERAPY, TO ACHIEVE A FAECAL MICROBIOME COMMUNITY STRUCTURE AND METAGENOME CHANGES ASSOCIATED WITH SUSTAINED REMISSION IN PAEDIATRIC CROHN’S DISEASE (CD): INITIAL RESU

Charlotte M. Verburgt  1     Katherine A Dunn  2     Anthony R. Otley  2     Melvin B. Heyman  3     Sofia Verstraete  3     Whitney M. Sunseri  4     Francisco Sylvester  5     Tim G. de Meij  5     Andre M. Comeau  5     Morgan Langille  5     Wouter J. de Jonge  6     Marc Benninga  6     Johan E. Van Limbergen  6    
1 Amsterdam University Medical Centers - Loc. University of Amsterdam, Emma Children's Hospital, Amsterdam, Netherlands
2 Dalhousie University, Halifax, Canada
3 UCSF Benioff Children’s Hospital, University of California, San Francisco, United States
4 UPMC Children’s Hospital of Pittsburgh, Pittsburgh, United States
5 UNC Children’s Hospital, University of North Carolina, Chapel Hill, United States
6 Amsterdam Gastroenterology Endocrinology Metabolism, University of Amsterdam, Amsterdam, Netherlands

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing